Kurt Karst: FDA does a poor job of getting info to the public

The Food and Drug Administration has a special, streamlined process for approving generics. Trouble is, the public announcements of FDA's decisions often get bo...

Kurt Karst, director, Hyman, Phelps and McNamara

The Food and Drug Administration has a special, streamlined process for approving generics. Trouble is, the public announcements of FDA's decisions often get bottled up. Attorney Kurt Karst, a director at Hyman, Phelps and McNamara, tells Federal Drive with Tom Temin that irritates and frustrates everyone, including drug companies, investors, federal judges and the public.

 

Copyright © 2024 Federal News Network. All rights reserved. This website is not intended for users located within the European Economic Area.

Related Stories

    Department of Energy

    Energy Department illustrates how to get clean-energy projects going

    Read more
    Carnegie Mellon University Heinz College of Information Systems and Public PolicyVolcker Alliance Senior Fellow Dustin Brown conducts the first of four discussions with colleges and universities as part of the organization's

    Long-time OMB official lands COO post at SSA

    Read more